Structure-activity relationship of taxol inferring from docking taxol analogues to microtubule binding site

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 64, Issue 7-8, 2009, Pages 551-556

  Xiang, Fu ^a   Yu, Jiangyan ^a   Yin, Rui ^a   Ma, Yunfeng ^a   Yu, Longjiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Molecular docking; Structure activity relationship; Taxol; Tubulin

Indexed keywords

BRIDGED COMPOUND; DOCETAXEL; DRUG DERIVATIVE; ORTATAXEL; PACLITAXEL; TAXOID; TUBULIN;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; KINETICS; METABOLISM; MICROTUBULE; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS;

BINDING SITES; BRIDGED COMPOUNDS; KINETICS; MICROTUBULES; MODELS, MOLECULAR; PACLITAXEL; STRUCTURE-ACTIVITY RELATIONSHIP; TAXOIDS; THERMODYNAMICS; TUBULIN;

EID: 70350586603     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2009-7-814     Document Type: Article

References (25)

1. Barboni L., Giarlo G., Ricciutelli M., Ballini R., George G. I., VanderVelde D. G., Himes R. H., Wang M., Lakdawala A., and Snyder J. P. (2004), Synthesis, modeling, and anti-tubulin activity of a D-seco paclitaxel analogue. Org. Lett. 6, 461-464.
2. Beer M., Lenaz L., Amadori D., and Ortataxel Study Group (2008), Phase II study of ortataxel in taxaneresistant breast cancer. J. Clin. Oncol. (Meeting Abstracts) 26, 1066.
3. Crown J., O'Leary M., and Ooi W. (2004), Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience. Oncologist 9, 24-32.
4. Dubois J., Thoret S., Gueritte F., and Guenard D. (2000), Synthesis of 5(20) deoxydocetaxel, a new active docetaxel analogue. Tetrahedron Lett. 41, 3331-3334.
5. Geney R., Chen J., and Ojima I. (2005), Recent advances in the new generation taxane anticancer agents. Med. Chem. 1, 125-139.
6. Grant D. S., Williams T. L., Zahaczewsky M., and Dicker A. P. (2002), Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). Int. J. Cancer 104, 121-129.
7. Gueritte F. (2001), General and recent aspects of the chemistry and structure activity relationships of taxoids. Curr. Pharm. Design 7, 1229-1249.
8. Gueritte F., Guenard D., Lavelle F., Le Goff M., Mangatal L., and Potier P. (1991), Relationships between the structure of taxol analogues and their antimitotic activity. J. Med. Chem. 34, 992-998.
9. Gunatilaka A. A. L., Ramdayal F. D., Sarragiotto M. H., and Kingston D. G. I. (1999), Synthesis and biological evaluation of novel paclitaxel (taxol) D-ring modified analogues. J. Org. Chem. 64, 2694-2703.
10. Kingston D. G. I. (2001), Taxol, a molecule for all seasons. Chem. Commun. 10, 867-880.
11. Lowe J., Li H., Downing K. H., and Nogales E. (2001), Refined structure of αβ-tubulin at 3.5 Å resolution. J. Mol. Biol. 313, 1045-1057.
12. Manfredi J. J., Parness J., and Horwitz S. B. (1982), Taxol binds to cellular microtubules. J. Cell Biol. 94, 688-696.
13. Morris G. M., Goodsell D. S., Halliday R. S., Huey R., Hart W. E., Belew R. K., and Olson A. J. (1998), Automated docking using a lamarckian genetic algorithm and and empirical binding free energy function. J. Comput. Chem. 19, 1639-1662.
14. Pettersen E. F., Goddard T. D., Huang C. C., Couch G. S., Greenblatt D. M., Meng E. C., and Ferrin T. E. (2004), UCSF chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612.
15. Ponder J. W. and Case D. A. (2003), Force fields for protein simulations. Adv. Protein Chem. 66, 27-85.
16. Rao S., Horwitz S. B., and Ringel I. (1992), Direct photoaffinity labeling of tubulin with taxol. J. Natl. Cancer I 84, 785-788.
17. Rao S., He L., Chakravarty S., Ojima I., Orr G. A., and Horwitz S. B. (1999), Characterization of the taxol binding site on the microtubule. Identification of Arg282 in β-tubulin as the site of photoincorpora-tion of a 7-benzophenone analogue of taxol. J. Biol. Chem. 274, 37990-37994.
18. Rowinsky E. K. and Tolcher A. W. (2001), Antimicrotubule agents. In: Cancer Principles and Practice, 6th ed. (Devita Jr. V. T., Hellman S., and Rosenberg S. A., eds.). Lippincott Williams and Wilkins, Philadelphia, pp. 431-452.
19. Sanner M. F. (1999), Python: a programming language for software integration and development. J. Mol. Graph. 17, 57-61.
20. Schiff P. B., Fant J., and Horwitz S. B. (1979), Promotion of microtubule assembly in vitro by taxol. Nature 277, 665-667.
21. Tian D., Zhang J., Zhu Y., Li W., and Chen Y. (2007), Advances in structure-activity relationship of paclitaxel and bioactivity of analogues. J. Nanjing Normal Univ. (Engineering and Technology Edition) 7, 48-54.
22. Wang J., Wang W., Kollmanc P. A., and Case D. A. (2006), Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graph. 25, 247-260.
23. Wang L., Alcaraz A. A., Matesanz R., Yang C., Barasoain I., Diaz J. F., Li Y., Snyder J. P., and Fang W. (2007), Synthesis, biological evaluations, and tubulin binding poses of C-2α sulfur linked taxol analogues. Bioorg. Med. Chem. Lett. 17, 3191-3194.
24. Wittman M. D., Altstadt T. J., Kadow J. F., Vyas D. M., Johnston K. A., Fairchild C. R., and Long B. H. (1999), Stereospecific synthesis of 7-deoxy-6-hydroxy paclitaxel. Tetrahedron Lett. 40, 4943-4946.
25. Xue M., Long B. H., Fairchild C., Johnston K., Rose W. C., Kadow J. F., Vyas D. M., and Chen S. (2000), Structure-activity relationships study at the 3′-N position of paclitaxel. Part 2: Synthesis and biological evaluation of 3′-N-thiourea- and 3′-N-thiocarbamate- bearing paclitaxel analogues. Bioorg. Med. Chem. Lett. 10, 1327-1331.